UPMC Mercy is a main hospital facility of the University of Pittsburgh Medical Center and is located in the Uptown section of the city of Pittsburgh, Pennsylvania, adjacent to Duquesne University, and a few blocks from the PPG Paints Arena and downtown Pittsburgh.

There are 404 beds in Mercy Hospital of Pittsburgh.

During the past decade, Mercy Hospital of Pittsburgh conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 15 clinical trials were completed, i.e. on average, 46.9% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 8 clinical trials were completed. i.e. 42.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Hospital of Pittsburgh" #1 sponsor was "Radiation Therapy Oncology Group" with 38 trials, followed by "National Cancer Institute (NCI)" with 8 trials sponsored, "University of Pittsburgh" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored and "SWOG Cancer Research Network" with 5 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Hospital of Pittsburgh" #1 collaborator was "National Cancer Institute (NCI)" with 49 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator, "Medical University of South Carolina" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Hospital of Pittsburgh" are "Head and Neck Cancer" (8 trials), "Prostate Cancer" (8 trials), "Brain and Central Nervous System Tumors" (6 trials), "Lung Cancer" (6 trials) and "Metastatic Cancer" (4 trials). Many other conditions were trialed in "Mercy Hospital of Pittsburgh" in a lesser frequency.

Most popular intervention types in "Mercy Hospital of Pittsburgh" are "Drug" (58 trials), "Radiation" (39 trials), "Procedure" (27 trials), "Biological" (18 trials) and "Other" (12 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (32 trials), "cisplatin" (9 trials), "conventional surgery" (8 trials), "paclitaxel" (7 trials) and "Computed Tomography" (6 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Hospital of Pittsburgh" are 70 trials for "All" genders, 7 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Mercy Hospital of Pittsburgh". undefined are not yet recruiting, 14 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Mercy Hospital of Pittsburgh, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Hospital of Pittsburgh, 9 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".